Hans-Dieter Volk is a clinical immunologist whose career centers on personalized immunotherapies and regenerative medicine. His profile combines senior academic leadership, biotechnology roles, extensive publications, and international scientific service. • From 1994 to 2021, he held Charité professorships and served as founding director of the BIH Center for Regenerative Therapies. • Since 2022, he has led the Biomarkers and Model Systems group and served as CSO of CheckImmune; since 2023, he has also been CSO of tc-Balance Biopharmaceutics. • His output exceeds 800 peer-reviewed articles and 50,000 citations, with a Google Scholar H-index of 116 and i10-index of 552; honors include the 1998 Humboldt Award.